Z

Zenas Biopharma Inc
NASDAQ:ZBIO

Watchlist Manager
Zenas Biopharma Inc
NASDAQ:ZBIO
Watchlist
Price: 19.1 USD -7.33% Market Closed
Market Cap: 760m USD
Have any thoughts about
Zenas Biopharma Inc?
Write Note

Wall Street
Price Targets

ZBIO Price Targets Summary
Zenas Biopharma Inc

Wall Street analysts forecast ZBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZBIO is 37.49 USD with a low forecast of 27.27 USD and a high forecast of 47.25 USD.

Lowest
Price Target
27.27 USD
43% Upside
Average
Price Target
37.49 USD
96% Upside
Highest
Price Target
47.25 USD
147% Upside

ZBIO Last Price Targets
Zenas Biopharma Inc

The latest public price target was made on Oct 8, 2024 by Roger Song from Jefferies , who expects ZBIO stock to rise by 83% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Roger Song
Jefferies
35 USD
Upside 83%
1 month ago
Oct 8, 2024
Zenas BioPharma initiated with a Buy at Jefferies
TheFly
Roger Song
Jefferies
Price Target 35 USD
Upside/Downside 83%
View Source
Zenas Biopharma Inc Competitors:
Price Targets
UTHR
United Therapeutics Corp
4% Downside
EXAI
Exscientia PLC
3% Downside
IMTX
Immatics NV
125% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
46% Upside
2696
Shanghai Henlius Biotech Inc
13% Upside
COYA
Coya Therapeutics Inc
120% Upside
KMDA
Kamada Ltd
137% Upside
BAVA
Bavarian Nordic A/S
56% Upside

Revenue
Forecast

Revenue Estimate
Zenas Biopharma Inc

The compound annual growth rate of Zenas Biopharma Inc's revenue for the next 3 years is -5%.

N/A
Past Growth
-5%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Zenas Biopharma Inc

Operating Income forecast
is not available for
Zenas Biopharma Inc

Net Income
Forecast

Net Income Estimate
Zenas Biopharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZBIO's stock price target?
Price Target
37.49 USD

According to Wall Street analysts, the average 1-year price target for ZBIO is 37.49 USD with a low forecast of 27.27 USD and a high forecast of 47.25 USD.

What is Zenas Biopharma Inc's Revenue forecast?
Projected CAGR
-5%

The compound annual growth rate of Zenas Biopharma Inc's revenue for the next 3 years is -5%.

Back to Top